-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer after hepatocellular carcinoma (HCC).
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer after hepatocellular carcinoma (HCC).
Researchers collected 12 newly diagnosed ICC patients who underwent R0 resection between March 2009 and 2019 and followed up
The results show that double negative AFP and CA19-9 lower proportion of patients at risk for lymph node transfer of advanced tumors, and larger tumor size, multiple tumors, lymph node metastasis, micro- vascular risk violations and violations of the surrounding nerves
Blood vessel
This study confirmed that the double negative of CA19-9 and AFP indicates that ICC patients have less aggressive tumors
This study confirmed that the double negative of CA19-9 and AFP indicates that ICC patients have less aggressive tumors
Zhang, Xiaoyun.
Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good Prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.
Leave a message here